these tumors were phenotypically negative for hla-dr prior to therapy , but after 4 days of treatment , 80 % of the cells expressed this antigen in vivo as assessed by immunoperoxidase ( f. r. balkwill et al. , eur . j. cancer clin . oncol. , in press , 1986 ) .
C0027651
tumors
C0006826
cancer